Matrivax Research & Development Corporation
PrivateLast Round
M&A
May 5, 2026
Total Funding Raised
$100,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Matrivax Research & Development Corporation is a biotechnology company that develops human vaccines and immunotherapeutics for the prevention and treatment of life-threatening bacterial diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Matrivax Research & Development Corporation Comparables
Compare Matrivax Research & Development Corporation with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Omniose | 81% | |
| Syntiron | 77% | |
| GSK plc | 77% |
Matrivax Research & Development Corporation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | May 5, 2026 | ||||
| Grant | Nov 1, 2009 | ||||
| VC Round | Oct 1, 2007 |
Matrivax Research & Development Corporation Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Morningside Ventures | VC Round |
| Bill & Melinda Gates Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 5, 2026
Elaris FlexCo participated in the M&A round.
- Nov 1, 2009
$100K grant from Bill & Melinda Gates Foundation.
Matrivax Research & Development Corporation Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Matrivax Research & Development Corporation's valuation, stock price, and market status.
Is Matrivax Research & Development Corporation a public or private company?
Matrivax Research & Development Corporation is a private company.
What is the current stock price of Matrivax Research & Development Corporation?
Matrivax Research & Development Corporation is a private company with no public stock price. No recent secondary market data is available.
How much is Matrivax Research & Development Corporation worth (valuation)?
Valuation information for Matrivax Research & Development Corporation is not publicly available.
Can I buy Matrivax Research & Development Corporation stock?
Matrivax Research & Development Corporation shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Matrivax Research & Development Corporation's last funding round?
Matrivax Research & Development Corporation's most recent funding round was M&A on May 5, 2026.
Who are the main investors in Matrivax Research & Development Corporation?
Key investors in Matrivax Research & Development Corporation include Morningside Ventures, Bill & Melinda Gates Foundation.
Will Matrivax Research & Development Corporation IPO soon?
No public IPO plans have been announced for Matrivax Research & Development Corporation.
How can I track Matrivax Research & Development Corporation secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Matrivax Research & Development Corporation's secondary market activity and sign up for updates.